CHCHD2 and MELAS: In summary, we have identified nitazoxanide and its metabolite tizoxanide as a drug that stimulates MNRR1 transcription and shown that it reduces heteroplasmy in a cell culture model of MELAS and improves the phenotype in MELAS patient fibroblasts.